Can software make hospital pharmacists faster and safer?
NCT ID NCT05459155
First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time
Summary
This study tests whether a software tool called Synapse Medicine can help hospital pharmacists who work with medical teams make better and faster medication recommendations. The tool analyzes each patient's health information to flag potential drug-related risks, such as harmful interactions or incorrect doses. Researchers will compare the number and quality of pharmacist recommendations before and after using the tool, and also see how easy it is for pharmacists to use in their daily work. The goal is to see if this kind of decision support can reduce medication errors and improve patient safety in the hospital.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Synapse medicine platform, a software tool that analyzes drug-related risks based on each patient's clinical characteristics
- What this could lead to
- If effective, this tool could help hospital pharmacists catch medication problems more quickly and accurately, potentially reducing harmful drug events in patients.
- What could go wrong
- This is an early-stage study focused on pharmacist workflow, not direct patient outcomes. The tool may not improve recommendations or may be difficult to integrate into daily practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,485 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * any patient that the inpatient pharmacists care for on the inpatient medical team they round with Exclusion Criteria: * N/A
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastrointestinal diseases are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could type 1 diabetes hide liver problems in children?
- Muscle therapy may restore strength in dialysis patients
- A simple stool test might replace scopes for kids with gut issues
- Could a lung 'Second Look' system expand the donor pool?
- Can gut microbes hold the key to liver health?
- A simple blood test may spot severe bacterial infections faster in the ER